Found 16 matching trials
Safety and Efficacy Study of Glyco pMDI After Single and Repeated Administration
PHASE1The purpose of this study is to evaluate the safety and the efficacy of Gly...
Location
Medicines Evaluation Unit
Effect of Spacer Use on Exacerbation Risk in High-Risk Older Adults With Chronic Airway Diseases Receiving Triple Therapy
NAThis study evaluates whether adding a spacer device to triple inhaled thera...
Location
The Second Affiliated Hospital of Anhui Medical University
Study on Foster Efficacy Maintenance and Reliever vs Foster Maintenance + Salbutamol Reliever in Asthmatics (MART2)
PHASE3Primary objective:
The primary objective of the study was to compare the e...
Location
Chiesi Site No 103
Anti-Inflammatory Reliever South Africa
PHASE3This is a Phase 3 single-centre open label randomised controlled trial with...
Location
Africa Research Health Institute Clinical Trial Unit
Step-up to Medium Strength Triple Therapy vs High Strength ICS/LABA in Adult Asthmatics Uncontrolled on Medium Strength ICS/LABA
PHASE4The purpose of this phase IV Study is to compare the efficacy of CHF5993 (B...
Non Inferiority of Fixed Combination of Beclomethasone Dipropionate (BDP) + Formoterol Fumarate (FF) + Glycopyrronium Bromide (GB) Versus Combination of Fluticasone Furoate (FlF)/Vilanterol (VI) + Tiotropium Bromide in Chronic Obstructive Pulmonary Disease (COPD)
PHASE3The purpose of the study is to demonstrate the triple combination of beclom...
Location
Erzsebet Gondozohaz
A Phase II, 5-way Cross-over Study to Evaluate the Pharmacodynamics of "Nexthaler" Dry Powder Inhaler in COPD Patients
PHASE2The study aim is to compare the pharmacodynamic effects (cardiovascular eff...
Location
Medicine Evaluation Unit
A 6-week Dose Ranging Study of CHF 5259 pMDI in Subjects With Chronic Obstructive Pulmonary Disease
PHASE2The purpose of this study is to evaluate the dose-response of different dos...
Location
Chiesi Investigational Site
Study in Adult Patients With Moderate to Severe Asthma
PHASE3This study assessed the influence of pink vs. white pressurized metered-dos...
Location
Chiesi Clinical Trial Site 38011
Foster® pMDI (CHF 1535) Versus Symbicort® Turbohaler in COPD Patient (FORSYYN)
PHASE3Primary Objective
To demonstrate that CHF 1535 pMDI is non-inferior to Sym...
Location
Site 15604 - Anhui Provincial Hospital